MXL vs VRTX · rev $360.5M vs P/E 30, rev $12.00B
MaxLinear Inc (MXL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MXL revenue for 2024-12-31 was $360.5M. Net income was -$245.2M. Revenue was down 48.0% from 2023-12-31 to 2024-12-31. MXL currently screens at market cap $7.42B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MXL currently screens at market cap $7.42B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MXL and VRTX stock pages for the full models.
Not investment advice.